Effect of ocular surface reconstruction by using amniotic membrane transplant for symptomatic conjunctivochalasis on fluorescein clearance test results

Cornea

Volumn 27, Issue 6, 2008, Pages 644-649

  Maskin, Steven L ^a  

^a Florida USA   (United States)

Author keywords

Amniotic membrane transplantation; Conjunctivochalasis; Fluorescein clearance; Ocular surface reconstruction

Indexed keywords

FLUORESCEIN; EYE DROPS;

ADULT; AGED; AMNIOTIC MEMEBRANE TRANSPLANTATION; ARTICLE; CONJUNCTIVA DISEASE; CONJUNCTIVOCHALASIS; CORNEA TRANSPLANTATION; EYE SURGERY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; VISUAL ACUITY; AMNION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; LACRIMAL FLUID; LACRIMAL GLAND DISEASE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PLASTIC SURGERY; PROSPECTIVE STUDY; SECRETION; TRANSPLANTATION;

AGED; AGED, 80 AND OVER; AMNION; CONJUNCTIVAL DISEASES; FEMALE; FLUORESCEIN; HUMANS; LACRIMAL APPARATUS DISEASES; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; RECONSTRUCTIVE SURGICAL PROCEDURES; TEARS; VISUAL ACUITY;

EID: 47949101206     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000611376.96794.01     Document Type: Article

References (14)

1. Meller D, Tseng SCG. Conjunctivochalasis: literature review and possible pathophysiology. Surv Ophthalmol. 1998;43:225-232.
2. Murube J. Characteristics and etiology of conjunctivochalasis: historical perspective. Ocul Surf. 2005;3:7-14.
3. Di Pascuale MA, Espana EM, Kawakita T, et al. Clinical characteristics of conjunctivochalasis with or without aqueous tear deficiency. Br J Ophthalmol. 2004;88:388-392.
4. Prabhasawat P, Tseng SCG. Frequent association of delayed tear clearance in ocular irritation. Br J Ophthalmol. 1998;82:666-675.
5. Meller D, Maskin SL, Pires RTF, et al. Amniotic membrane transplantation for symptomatic conjunctivochalasis refractory to medical treatments. Cornea. 2000;19:796-803.
6. Georgiadis NS, Terzidou CD. Epiphora caused by conjunctivochalasis. Treatment with transplantation of preserved human amniotic membrane. Cornea. 2001;20:619-621.
7. Pflugfelder SC. Anti-inflammatory therapy of dry eye. Ocul Surf. 2003;1: 31-36.
8. Pflugfelder SC, Maskin SL, Anderson B, et al. A randomized, doublemasked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol. 2004;138:444-457.
9. Yokoi N, Komuro A, Nishii M, et al. Clinical impact of conjunctivochalasis on the ocular surface. Cornea. 2005;24(Suppl 1):S24-S31.
10. Li DQ, Meller D, Liu Y, et al. Overexpression of MMP-1 and MMP-3 by cultured conjunctivochalasis fibroblasts. Invest Ophthalmol Vis Sci. 2000; 41:404-410.
11. Erdogan-Poyraz C, Mocan MC, Irkec M, et al. Delayed tear clearance in patients with conjunctivochalasis is associated with punctal occlusion. Cornea. 2007;26:290-293.
12. Tseng SC, Espana EM, Kawakita T, et al. How does amniotic membrane work? Ocul Surf. 2004;2:177-187.
13. Touhami A, Grueterich M, Tseng SC. The role of NGF signaling in human limbal epithelium expanded by amniotic membrane culture. Invest Ophthalmol Vis Sci. 2002;43:987-994.
14. Bonini S, Lambiase A, Rama P, et al. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology. 2000;107:1347-1352.